News Conference News ACC 2022 Tailored Nutrition Advice at the Grocery Store Works: SuperWIN Caitlin E. Cox April 03, 2022
News Daily News A ‘Call to Action’ for HF Trials: More Black, Hispanic Patients Caitlin E. Cox March 31, 2022
News Daily News Surgical Societies Question VARC-3 Endpoints for Valve Disease Trials Michael O'Riordan March 23, 2022
News Daily News Subclinical Leaflet Thrombosis After TAVI Linked to Higher Mortality Michael O'Riordan March 10, 2022
News Daily News Good Results For TAVI in Bicuspid Valves, but Questions Persist Michael O'Riordan March 08, 2022
News Daily News Homozygous FH Diagnosis Often Comes Late, With Lackluster Care Michael O'Riordan February 10, 2022
News Conference News STS 2022 Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients Todd Neale February 02, 2022
News Daily News Lower Costs for TAVI Valves Could Improve Access, Analysis Hints Yael L. Maxwell January 24, 2022
News Opinion Conversations in Cardiology Conversations in Cardiology: Time for an Interventional Fellowship Match? January 24, 2022
News Daily News ‘Home Time’ Validated as TAVI Outcomes Performance Metric L.A. McKeown January 11, 2022
News Daily News Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines L.A. McKeown December 28, 2021
News Daily News New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT Michael O'Riordan December 09, 2021
News Daily News SWEDEHEART Affirms SAVR’s Long-term Benefits in Young, Low-Risk AS L.A. McKeown November 30, 2021
News Conference News AHA 2021 Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE Shelley Wood November 14, 2021
News Conference News AHA 2021 RAPID CABG: No Penalty to Early Surgery for ACS After Stopping Ticagrelor Yael L. Maxwell November 13, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
Presentation TCT 2021 PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk Presenter: David Cohen November 05, 2021